{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:00:24Z","timestamp":1790625624347,"version":"4.1.0"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-021-08908-8","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:04:12Z","timestamp":1642464252000},"page":"33-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"64","author":[{"given":"Rundong","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-7793","authenticated-orcid":false,"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"8908_CR1","unstructured":"World Health Organization (2021) WHO Coronavirus (COVID-19) Dashboard. Available at https:\/\/covid19.who.int\/"},{"key":"8908_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"8908_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 395:514\u2013523. https:\/\/doi.org\/10.1016\/s0140-6736(20)30154-9","journal-title":"Lancet"},{"key":"8908_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395:507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"8908_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaci.2020.05.003","volume":"146","author":"R Chen","year":"2020","unstructured":"Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W et al (2020) Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol 146:89\u2013100. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.003","journal-title":"J Allergy Clin Immunol"},{"key":"8908_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 323:1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"8908_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"8908_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2195","volume":"31","author":"K Liu","year":"2021","unstructured":"Liu K, Yang T, Peng XF, Lv SM, Ye XL, Zhao TS et al (2021) A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol 31:e2195. https:\/\/doi.org\/10.1002\/rmv.2195","journal-title":"Rev Med Virol"},{"key":"8908_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","volume":"58","author":"BM Henry","year":"2020","unstructured":"Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G (2020) Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med 58:1021\u20131028. https:\/\/doi.org\/10.1515\/cclm-2020-0369","journal-title":"Clin Chem Lab Med"},{"key":"8908_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fmed.2020.00301","volume":"7","author":"X Feng","year":"2020","unstructured":"Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M et al (2020) Immune-inflammatory parameters in COVID-19 cases: A systematic review and meta-analysis. Front Med (Lausanne) 7:301. https:\/\/doi.org\/10.3389\/fmed.2020.00301","journal-title":"Front Med (Lausanne)"},{"key":"8908_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fcimb.2020.00364","volume":"10","author":"M Jesenak","year":"2020","unstructured":"Jesenak M, Brndiarova M, Urbancikova I, Rennerova Z, Vojtkova J, Bobcakova A et al (2020) Immune parameters and COVID-19 infection - associations with clinical severity and disease prognosis. Front Cell Infect Microbiol 10:364. https:\/\/doi.org\/10.3389\/fcimb.2020.00364","journal-title":"Front Cell Infect Microbiol"},{"key":"8908_CR12","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.jaci.2021.03.047","volume":"147","author":"K Dorgham","year":"2021","unstructured":"Dorgham K, Quentric P, G\u00f6kkaya M, Marot S, Parizot C, Sauce D et al (2021) Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol 147:2098\u20132107. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.047","journal-title":"J Allergy Clin Immunol"},{"key":"8908_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijid.2020.09.1438","volume":"101","author":"M Vassallo","year":"2020","unstructured":"Vassallo M, Manni S, Pini P, Blanchouin E, Ticchioni M, Seitz-Polski B et al (2020) Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation. Int J Infect Dis 101:174\u2013179. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1438","journal-title":"Int J Infect Dis"},{"key":"8908_CR14","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1182\/bloodadvances.2020002650","volume":"4","author":"M Osman","year":"2020","unstructured":"Osman M, Faridi RM, Sligl W, Shabani-Rad MT, Dharmani-Khan P, Parker A et al (2020) Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19. Blood Adv 4:5035\u20135039. https:\/\/doi.org\/10.1182\/bloodadvances.2020002650","journal-title":"Blood Adv"},{"key":"8908_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13017-020-00323-2","volume":"15","author":"G Bolondi","year":"2020","unstructured":"Bolondi G, Russo E, Gamberini E, Circelli A, Meca MCC, Brogi E et al (2020) Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: An observational cohort study. World J Emerg Surg 15:41. https:\/\/doi.org\/10.1186\/s13017-020-00323-2","journal-title":"World J Emerg Surg"},{"key":"8908_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-021-01268-w","volume":"22","author":"J Trigo","year":"2021","unstructured":"Trigo J, Garc\u00eda-Azor\u00edn D, Sierra-Menc\u00eda \u00c1, Tamayo-Velasco \u00c1, Mart\u00ednez-Paz P, Tamayo E et al (2021) Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients. J Headache Pain 22:51. https:\/\/doi.org\/10.1186\/s10194-021-01268-w","journal-title":"J Headache Pain"},{"key":"8908_CR17","unstructured":"National Health Commission of the People\u2019s Republic of China (2021) COVID-19 Diagnosis and Treatment Guideline in China (Interim version 8). Available at https:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-08\/19\/5535757\/files\/da89edf7cc9244fbb34ecf6c61df40bf.pdf"},{"key":"8908_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 27:1785\u20131805. https:\/\/doi.org\/10.1177\/0962280216669183","journal-title":"Stat Methods Med Res"},{"key":"8908_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1429","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng XT, Lin L, Chu H et al (2020) Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. https:\/\/doi.org\/10.1002\/jrsm.1429","journal-title":"Res Synth Methods"},{"key":"8908_CR20","first-page":"851","volume":"16","author":"BKJ Zhang","year":"2016","unstructured":"Zhang BKJ, Chen XM (2016) Methods to combine standard deviations of different subgroups in meta-analysis. Chin J Evid Based Med 16:851\u2013854","journal-title":"Chin J Evid Based Med"},{"key":"8908_CR21","doi-asserted-by":"publisher","first-page":"16726","DOI":"10.1038\/s41598-020-73962-9","volume":"10","author":"DJ Altschul","year":"2020","unstructured":"Altschul DJ, Unda SR, Benton J, de la Garza RR, Cezayirli P, Mehler M et al (2020) A novel severity score to predict inpatient mortality in COVID-19 patients. Sci Rep 10:16726. https:\/\/doi.org\/10.1038\/s41598-020-73962-9","journal-title":"Sci Rep"},{"key":"8908_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/20009666.2020.1816276","volume":"10","author":"MS Asghar","year":"2020","unstructured":"Asghar MS, Khan NA, Haider Kazmi SJ, Ahmed A, Hassan M, Jawed R et al (2020) Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: A retrospective comparative analysis. J Community Hosp Intern Med Perspect 10:514\u2013520. https:\/\/doi.org\/10.1080\/20009666.2020.1816276","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"8908_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.resinv.2020.07.004","volume":"58","author":"N Awano","year":"2020","unstructured":"Awano N, Inomata M, Kuse N, Tone M, Takada K, Muto Y et al (2020) Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019. Respir Investig 58:440\u2013447. https:\/\/doi.org\/10.1016\/j.resinv.2020.07.004","journal-title":"Respir Investig"},{"key":"8908_CR24","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","volume":"26","author":"J Berenguer","year":"2020","unstructured":"Berenguer J, Ryan P, Rodr\u00edguez-Ba\u00f1o J, Jarr\u00edn I, Carratal\u00e0 J, Pach\u00f3n J et al (2020) Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 26:1525\u20131536. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.024","journal-title":"Clin Microbiol Infect"},{"key":"8908_CR25","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1111\/all.14309","volume":"75","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z et al (2020) COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy 75:1742\u20131752. https:\/\/doi.org\/10.1111\/all.14309","journal-title":"Allergy"},{"key":"8908_CR26","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.7150\/thno.47980","volume":"10","author":"J Cao","year":"2020","unstructured":"Cao J, Zheng Y, Luo Z, Mei Z, Yao Y, Liu Z et al (2020) Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics 10:9663\u20139673. https:\/\/doi.org\/10.7150\/thno.47980","journal-title":"Theranostics"},{"key":"8908_CR27","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/jci137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/jci137244","journal-title":"J Clin Invest"},{"key":"8908_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1080\/21505594.2020.1840122","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Han T, Huang M, Yang Y, Shang F, Zheng Y et al (2020) Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province. Virulence 11:1557\u20131568. https:\/\/doi.org\/10.1080\/21505594.2020.1840122","journal-title":"Virulence"},{"key":"8908_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3760\/cma.j.issn.1001-0939.2020.03.013","volume":"43","author":"L Chen","year":"2020","unstructured":"Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J et al (2020) Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 43:203\u2013208. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2020.03.013","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"8908_CR30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/gerona\/glaa089","volume":"75","author":"T Chen","year":"2020","unstructured":"Chen T, Dai Z, Mo P, Li X, Ma Z, Song S et al (2020) Clinical characteristics and outcomes of older patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective study. J Gerontol A Biol Sci Med Sci 75:1788\u20131795. https:\/\/doi.org\/10.1093\/gerona\/glaa089","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8908_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ 368:m1091. https:\/\/doi.org\/10.1136\/bmj.m1091","journal-title":"BMJ"},{"key":"8908_CR32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y et al (2020) Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated Interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 71:1937\u20131942. https:\/\/doi.org\/10.1093\/cid\/ciaa449","journal-title":"Clin Infect Dis"},{"key":"8908_CR33","first-page":"549","volume":"42","author":"YJRL Chen","year":"2020","unstructured":"Chen YJRL, Pang XH, Mou HM, Wang JB, Lang CH et al (2020) Clinical features of coronavirus disease 2019 in Northeast area of Chongqing: Analysis of 143 cases. J Third Mil Med Univ 42:549\u2013554","journal-title":"J Third Mil Med Univ"},{"key":"8908_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","volume":"222","author":"Y Chi","year":"2020","unstructured":"Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T et al (2020) Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. J Infect Dis 222:746\u2013754. https:\/\/doi.org\/10.1093\/infdis\/jiaa363","journal-title":"J Infect Dis"},{"key":"8908_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12877-020-01803-5","volume":"20","author":"R Chinnadurai","year":"2020","unstructured":"Chinnadurai R, Ogedengbe O, Agarwal P, Money-Coomes S, Abdurrahman AZ, Mohammed S et al (2020) Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting - a cohort study. BMC Geriatr 20:409. https:\/\/doi.org\/10.1186\/s12877-020-01803-5","journal-title":"BMC Geriatr"},{"key":"8908_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108509","volume":"217","author":"F Ciceri","year":"2020","unstructured":"Ciceri F, Castagna A, Rovere-Querini P, De Cobelli F, Ruggeri A, Galli L et al (2020) Early predictors of clinical outcomes of COVID-19 outbreak in Milan. Italy Clin Immunol 217:108509. https:\/\/doi.org\/10.1016\/j.clim.2020.108509","journal-title":"Italy Clin Immunol"},{"key":"8908_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijid.2020.09.037","volume":"100","author":"ADA Monforte","year":"2020","unstructured":"Monforte ADA, Tavelli A, Bai F, Tomasoni D, Falcinella C, Castoldi R et al (2020) The importance of patients\u2019 case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease. Int J Infect Dis 100:67\u201374. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.037","journal-title":"Int J Infect Dis"},{"key":"8908_CR38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1111\/tbed.13651","volume":"67","author":"Y Dong","year":"2020","unstructured":"Dong Y, Zhou H, Li M, Zhang Z, Guo W, Yu T et al (2020) A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection. Transbound Emerg Dis 67:2823\u20132829. https:\/\/doi.org\/10.1111\/tbed.13651","journal-title":"Transbound Emerg Dis"},{"key":"8908_CR39","doi-asserted-by":"publisher","unstructured":"Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M et al (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study. Eur Respir J 55. https:\/\/doi.org\/10.1183\/13993003.00524-2020","DOI":"10.1183\/13993003.00524-2020"},{"key":"8908_CR40","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1002\/jmv.26082","volume":"92","author":"J Duan","year":"2020","unstructured":"Duan J, Wang X, Chi J, Chen H, Bai L, Hu Q et al (2020) Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing. J Med Virol 92:2616\u20132622. https:\/\/doi.org\/10.1002\/jmv.26082","journal-title":"J Med Virol"},{"key":"8908_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fmed.2020.00491","volume":"7","author":"X Feng","year":"2020","unstructured":"Feng X, Li P, Ma L, Liang H, Lei J, Li W et al (2020) Clinical characteristics and short-term outcomes of severe patients with COVID-19 in Wuhan, China. Front Med (Lausanne) 7:491. https:\/\/doi.org\/10.3389\/fmed.2020.00491","journal-title":"Front Med (Lausanne)"},{"key":"8908_CR42","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","volume":"201","author":"Y Feng","year":"2020","unstructured":"Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J et al (2020) COVID-19 with different severities: A multicenter study of clinical features. Am J Respir Crit Care Med 201:1380\u20131388. https:\/\/doi.org\/10.1164\/rccm.202002-0445OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8908_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104611","volume":"131","author":"R Gozalbo-Rovira","year":"2020","unstructured":"Gozalbo-Rovira R, Gimenez E, Latorre V, Franc\u00e9s-G\u00f3mez C, Albert E, Buesa J et al (2020) SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. J Clin Virol 131:104611. https:\/\/doi.org\/10.1016\/j.jcv.2020.104611","journal-title":"J Clin Virol"},{"key":"8908_CR44","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.2147\/idr.S263157","volume":"13","author":"L Guo","year":"2020","unstructured":"Guo L, Xiong W, Liu D, Feng Y, Wang P, Dong X et al (2020) The mNCP-SPI score predicting risk of severe COVID-19 among mild-pneumonia patients on admission. Infect Drug Resist 13:3593\u20133600. https:\/\/doi.org\/10.2147\/idr.S263157","journal-title":"Infect Drug Resist"},{"key":"8908_CR45","doi-asserted-by":"publisher","unstructured":"Gupta N, Ish P, Kumar R, Dev N, Yadav SR, Malhotra N et al (2020) Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India. Monaldi Arch Chest Dis 90. https:\/\/doi.org\/10.4081\/monaldi.2020.1507","DOI":"10.4081\/monaldi.2020.1507"},{"key":"8908_CR46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00430-020-00693-z","volume":"209","author":"M Han","year":"2020","unstructured":"Han M, Xu M, Zhang Y, Liu Z, Li S, He T et al (2020) Assessing SARS-CoV-2 RNA levels and lymphocyte\/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity. Med Microbiol Immunol 209:657\u2013668. https:\/\/doi.org\/10.1007\/s00430-020-00693-z","journal-title":"Med Microbiol Immunol"},{"key":"8908_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104361","volume":"127","author":"R He","year":"2020","unstructured":"He R, Lu Z, Zhang L, Fan T, Xiong R, Shen X et al (2020) The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol 127:104361. https:\/\/doi.org\/10.1016\/j.jcv.2020.104361","journal-title":"J Clin Virol"},{"key":"8908_CR48","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/jmv.26174","volume":"92","author":"H Huang","year":"2020","unstructured":"Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J et al (2020) Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China. J Med Virol 92:2742\u20132750. https:\/\/doi.org\/10.1002\/jmv.26174","journal-title":"J Med Virol"},{"key":"8908_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108448","volume":"169","author":"Y Huang","year":"2020","unstructured":"Huang Y, Guo H, Zhou Y, Guo J, Wang T, Zhao X et al (2020) The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes. Diabetes Res Clin Pract 169:108448. https:\/\/doi.org\/10.1016\/j.diabres.2020.108448","journal-title":"Diabetes Res Clin Pract"},{"key":"8908_CR50","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","volume":"202","author":"S Hue","year":"2020","unstructured":"Hue S, Beldi-Ferchiou A, Bendib I, Surenaud M, Fourati S, Frapard T et al (2020) Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome. Am J Respir Crit Care Med 202:1509\u20131519. https:\/\/doi.org\/10.1164\/rccm.202005-1885OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8908_CR51","doi-asserted-by":"publisher","first-page":"22369","DOI":"10.1038\/s41598-020-79508-3","volume":"10","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Abudurexiti S, An MM, Cao D, Wei J, Gong P (2020) Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: A retrospective observational study. Sci Rep 10:22369. https:\/\/doi.org\/10.1038\/s41598-020-79508-3","journal-title":"Sci Rep"},{"key":"8908_CR52","doi-asserted-by":"publisher","DOI":"10.1017\/s095026882000271x","volume":"148","author":"S Kazancioglu","year":"2020","unstructured":"Kazancioglu S, Bastug A, Ozbay BO, Kemirtlek N, Bodur H (2020) The role of haematological parameters in patients with COVID-19 and influenza virus infection. Epidemiol Infect 148:e272. https:\/\/doi.org\/10.1017\/s095026882000271x","journal-title":"Epidemiol Infect"},{"key":"8908_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104661","volume":"133","author":"C Lei","year":"2020","unstructured":"Lei C, Lin W, Deng X, Hu F, Chen F, Cai W et al (2020) Factors associated with clinical outcomes in patients with coronavirus disease 2019 in Guangzhou. China J Clin Virol 133:104661. https:\/\/doi.org\/10.1016\/j.jcv.2020.104661","journal-title":"China J Clin Virol"},{"key":"8908_CR54","unstructured":"Li D, Wang M, He B, Xu Y, Zhou XY, Li WJ et al (2020) Laboratory test analysis of sixty-two COVID-19 patients. Med J Wuhan Univ 1\u20135"},{"key":"8908_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12931-020-01411-2","volume":"21","author":"K Li","year":"2020","unstructured":"Li K, Chen D, Chen S, Feng Y, Chang C, Wang Z et al (2020) Predictors of fatality including radiographic findings in adults with COVID-19. Respir Res 21:146. https:\/\/doi.org\/10.1186\/s12931-020-01411-2","journal-title":"Respir Res"},{"key":"8908_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s15010-020-01446-z","volume":"48","author":"Q Li","year":"2020","unstructured":"Li Q, Zhang J, Ling Y, Li W, Zhang X, Lu H et al (2020) A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency. Infection 48:577\u2013584. https:\/\/doi.org\/10.1007\/s15010-020-01446-z","journal-title":"Infection"},{"key":"8908_CR57","doi-asserted-by":"publisher","unstructured":"Li S, Jiang L, Li X, Lin F, Wang Y, Li B et al (2020) Clinical and pathological investigation of patients with severe COVID-19. JCI Insight 5. https:\/\/doi.org\/10.1172\/jci.insight.138070","DOI":"10.1172\/jci.insight.138070"},{"key":"8908_CR58","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1016\/s2352-3026(20)30217-9","volume":"7","author":"D Liao","year":"2020","unstructured":"Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J et al (2020) Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: A retrospective cohort study. Lancet Haematol 7:e671\u2013e678. https:\/\/doi.org\/10.1016\/s2352-3026(20)30217-9","journal-title":"Lancet Haematol"},{"key":"8908_CR59","doi-asserted-by":"publisher","unstructured":"Ling YIY, Qian ZP, Huang D, Zhang DD, Li T et al (2020) Clinical analysis of risk factors for severe patients with novel coronavirus pneumonia. Chin J Infect Dis 193\u2013198. https:\/\/doi.org\/10.3760\/cma.j.cn311365-20200211-00055","DOI":"10.3760\/cma.j.cn311365-20200211-00055"},{"key":"8908_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104370","volume":"127","author":"F Liu","year":"2020","unstructured":"Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y et al (2020) Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 127:104370. https:\/\/doi.org\/10.1016\/j.jcv.2020.104370","journal-title":"J Clin Virol"},{"key":"8908_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102763","volume":"55","author":"J Liu","year":"2020","unstructured":"Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55:102763. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102763","journal-title":"EBioMedicine"},{"key":"8908_CR62","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fmed.2020.00432","volume":"7","author":"Y Lu","year":"2020","unstructured":"Lu Y, Sun K, Guo S, Wang J, Li A, Rong X et al (2020) Early warning indicators of severe COVID-19: A single-center study of cases from Shanghai. China Front Med (Lausanne) 7:432. https:\/\/doi.org\/10.3389\/fmed.2020.00432","journal-title":"China Front Med (Lausanne)"},{"key":"8908_CR63","unstructured":"Lu ZLHR, Jiang WY, Fan T, Geng Q (2020) Clinical characteristics and immune function analysis of COVID-19. Med J Wuhan Univ 41:529\u2013532\u2013546"},{"key":"8908_CR64","doi-asserted-by":"publisher","unstructured":"Luo M, Liu J, Jiang W, Yue S, Liu H, Wei S (2020) IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19. JCI Insight 5. https:\/\/doi.org\/10.1172\/jci.insight.139024","DOI":"10.1172\/jci.insight.139024"},{"key":"8908_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.micinf.2020.05.007","volume":"22","author":"Z Lv","year":"2020","unstructured":"Lv Z, Cheng S, Le J, Huang J, Feng L, Zhang B et al (2020) Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: A retrospective cohort study. Microbes Infect 22:195\u2013199. https:\/\/doi.org\/10.1016\/j.micinf.2020.05.007","journal-title":"Microbes Infect"},{"key":"8908_CR66","doi-asserted-by":"publisher","unstructured":"Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H et al (2020) Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa270","DOI":"10.1093\/cid\/ciaa270"},{"key":"8908_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041989","volume":"10","author":"JG Park","year":"2020","unstructured":"Park JG, Kang MK, Lee YR, Song JE, Kim NY, Kweon YO et al (2020) Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: A retrospective multicentre cohort study. BMJ Open 10:e041989. https:\/\/doi.org\/10.1136\/bmjopen-2020-041989","journal-title":"BMJ Open"},{"key":"8908_CR68","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1681\/asn.2020030276","volume":"31","author":"G Pei","year":"2020","unstructured":"Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C et al (2020) Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 31:1157\u20131165. https:\/\/doi.org\/10.1681\/asn.2020030276","journal-title":"J Am Soc Nephrol"},{"key":"8908_CR69","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71:762\u2013768. https:\/\/doi.org\/10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"8908_CR70","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/s2213-2600(20)30366-0","volume":"8","author":"P Sinha","year":"2020","unstructured":"Sinha P, Calfee CS, Cherian S, Brealey D, Cutler S, King C et al (2020) Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: A prospective observational study. Lancet Respir Med 8:1209\u20131218. https:\/\/doi.org\/10.1016\/s2213-2600(20)30366-0","journal-title":"Lancet Respir Med"},{"key":"8908_CR71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cca.2020.05.027","volume":"508","author":"DW Sun","year":"2020","unstructured":"Sun DW, Zhang D, Tian RH, Li Y, Wang YS, Cao J et al (2020) The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? Clin Chim Acta 508:122\u2013129. https:\/\/doi.org\/10.1016\/j.cca.2020.05.027","journal-title":"Clin Chim Acta"},{"key":"8908_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102473","volume":"112","author":"Y Sun","year":"2020","unstructured":"Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C et al (2020) Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun 112:102473. https:\/\/doi.org\/10.1016\/j.jaut.2020.102473","journal-title":"J Autoimmun"},{"key":"8908_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108486","volume":"217","author":"JM Urra","year":"2020","unstructured":"Urra JM, Cabrera CM, Porras L, R\u00f3denas I (2020) Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients. Clin Immunol 217:108486. https:\/\/doi.org\/10.1016\/j.clim.2020.108486","journal-title":"Clin Immunol"},{"key":"8908_CR74","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bjh.16659","volume":"189","author":"S Wan","year":"2020","unstructured":"Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L et al (2020) Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol 189:428\u2013437. https:\/\/doi.org\/10.1111\/bjh.16659","journal-title":"Br J Haematol"},{"key":"8908_CR75","doi-asserted-by":"publisher","first-page":"668","DOI":"10.4158\/ep-2020-0108","volume":"26","author":"F Wang","year":"2020","unstructured":"Wang F, Yang Y, Dong K, Yan Y, Zhang S, Ren H et al (2020) Clinical charactheristics of 28 patients with diabetes and COVID-19 in Wuhan, China. Endocr Pract 26:668\u2013674. https:\/\/doi.org\/10.4158\/ep-2020-0108","journal-title":"Endocr Pract"},{"key":"8908_CR76","doi-asserted-by":"publisher","unstructured":"Wang H, Xing Y, Yao X, Li Y, Huang J, Tang J et al (2020) Retrospective study of clinical features of COVID-19 in inpatients and their association with disease severity. Med Sci Monit 26:e927674. https:\/\/doi.org\/10.12659\/msm.927674","DOI":"10.12659\/msm.927674"},{"key":"8908_CR77","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9945","volume":"8","author":"J Wang","year":"2020","unstructured":"Wang J, Yu H, Hua Q, Jing S, Liu Z, Peng X et al (2020) A descriptive study of random forest algorithm for predicting COVID-19 patients outcome. PeerJ 8:e9945. https:\/\/doi.org\/10.7717\/peerj.9945","journal-title":"PeerJ"},{"key":"8908_CR78","doi-asserted-by":"publisher","first-page":"300060520955037","DOI":"10.1177\/0300060520955037","volume":"48","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang H, Qiao R, Ge Q, Zhang S, Zhao Z et al (2020) Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score. J Int Med Res 48:300060520955037. https:\/\/doi.org\/10.1177\/0300060520955037","journal-title":"J Int Med Res"},{"key":"8908_CR79","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jinf.2020.03.019","volume":"80","author":"L Wang","year":"2020","unstructured":"Wang L, He W, Yu X, Hu D, Bao M, Liu H et al (2020) Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect 80:639\u2013645. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.019","journal-title":"J Infect"},{"key":"8908_CR80","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/inf.0000000000002739","volume":"39","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhu F, Wang C, Wu J, Liu J, Chen X et al (2020) Children hospitalized with severe COVID-19 in Wuhan. Pediatr Infect Dis J 39:e91\u2013e94. https:\/\/doi.org\/10.1097\/inf.0000000000002739","journal-title":"Pediatr Infect Dis J"},{"key":"8908_CR81","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R (2020) Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 71:769\u2013777. https:\/\/doi.org\/10.1093\/cid\/ciaa272","journal-title":"Clin Infect Dis"},{"key":"8908_CR82","doi-asserted-by":"publisher","first-page":"2138387","DOI":"10.1155\/2020\/2138387","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Ye D, Wang M, Zhao M, Li D, Ye J et al (2020) Clinical features of COVID-19 patients with different outcomes in Wuhan: A retrospective observational study. Biomed Res Int 2020:2138387. https:\/\/doi.org\/10.1155\/2020\/2138387","journal-title":"Biomed Res Int"},{"key":"8908_CR83","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180:934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"8908_CR84","first-page":"154","volume":"19","author":"TXLJ Xiang","year":"2020","unstructured":"Xiang TXLJ, Xu F, Cheng N, Liu Y, Qian KJ et al (2020) Analysis of clinical characteristics of 49 patients with coronavirus disease 2019 in Jiangxi. Chin J Resp Crit Care Med 19:154\u2013160","journal-title":"Chin J Resp Crit Care Med"},{"key":"8908_CR85","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/jmv.25930","volume":"92","author":"J Xie","year":"2020","unstructured":"Xie J, Ding C, Li J, Wang Y, Guo H, Lu Z et al (2020) Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J Med Virol 92:2004\u20132010. https:\/\/doi.org\/10.1002\/jmv.25930","journal-title":"J Med Virol"},{"key":"8908_CR86","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12879-020-05452-2","volume":"20","author":"S Xiong","year":"2020","unstructured":"Xiong S, Liu L, Lin F, Shi J, Han L, Liu H et al (2020) Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: A single-centered, retrospective, observational study. BMC Infect Dis 20:787. https:\/\/doi.org\/10.1186\/s12879-020-05452-2","journal-title":"BMC Infect Dis"},{"key":"8908_CR87","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jinf.2020.04.012","volume":"81","author":"B Xu","year":"2020","unstructured":"Xu B, Fan CY, Wang AL, Zou YL, Yu YH, He C et al (2020) Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. J Infect 81:e51\u2013e60. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.012","journal-title":"J Infect"},{"key":"8908_CR88","doi-asserted-by":"publisher","unstructured":"Xu J, Han MF, Zhao FD, Zhang T, Ma L (2020) Clinical manifestations and sero-immunological characteristics of 155 patients with COVID-19. Chin J Nosocomiol 2261\u20132265. https:\/\/doi.org\/10.11816\/cn.ni.2020-200577","DOI":"10.11816\/cn.ni.2020-200577"},{"key":"8908_CR89","doi-asserted-by":"publisher","unstructured":"Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X et al (2020) Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care 8. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001343","DOI":"10.1136\/bmjdrc-2020-001343"},{"key":"8908_CR90","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/jmv.25972","volume":"92","author":"F Yang","year":"2020","unstructured":"Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X (2020) Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol 92:2067\u20132073. https:\/\/doi.org\/10.1002\/jmv.25972","journal-title":"J Med Virol"},{"key":"8908_CR91","unstructured":"Yang H, Yang LC, Zhang RT, Ling YP, Ge QG (2020) Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes. J Peking Univ (Health Sci) 52:420\u2013424"},{"key":"8908_CR92","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","volume":"146","author":"Y Yang","year":"2020","unstructured":"Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F et al (2020) Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol 146:119-127.e114. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.027","journal-title":"J Allergy Clin Immunol"},{"key":"8908_CR93","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2147\/jir.S280331","volume":"13","author":"J Yuan","year":"2020","unstructured":"Yuan J, Kou S, Liang Y, Lan J, Li X, Zeng L et al (2020) Immunological evaluation on potential treatment window for hospitalized COVID-19 patients. J Inflamm Res 13:985\u2013993. https:\/\/doi.org\/10.2147\/jir.S280331","journal-title":"J Inflamm Res"},{"key":"8908_CR94","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/ijlh.13291","volume":"42","author":"H Zhang","year":"2020","unstructured":"Zhang H, Cao X, Kong M, Mao X, Huang L, He P et al (2020) Clinical and hematological characteristics of 88 patients with COVID-19. Int J Lab Hematol 42:780\u2013787. https:\/\/doi.org\/10.1111\/ijlh.13291","journal-title":"Int J Lab Hematol"},{"key":"8908_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104392","volume":"127","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yu M, Tong S, Liu LY, Tang LV (2020) Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan. China J Clin Virol 127:104392. https:\/\/doi.org\/10.1016\/j.jcv.2020.104392","journal-title":"China J Clin Virol"},{"key":"8908_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107666","volume":"34","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wei Y, Chen M, Wan Q, Chen X (2020) Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes. J Diabetes Complications 34:107666. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107666","journal-title":"J Diabetes Complications"},{"key":"8908_CR97","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40249-020-00723-1","volume":"9","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Nie HX, Hu K, Wu XJ, Zhang YT, Wang MM et al (2020) Abnormal immunity of non-survivors with COVID-19: Predictors for mortality. Infect Dis Poverty 9:108. https:\/\/doi.org\/10.1186\/s40249-020-00723-1","journal-title":"Infect Dis Poverty"},{"key":"8908_CR98","doi-asserted-by":"publisher","unstructured":"Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J et al (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5. https:\/\/doi.org\/10.1172\/jci.insight.139834","DOI":"10.1172\/jci.insight.139834"},{"key":"8908_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104366","volume":"127","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Xu H, Yang M, Zeng Y, Chen H, Liu R et al (2020) Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. J Clin Virol 127:104366. https:\/\/doi.org\/10.1016\/j.jcv.2020.104366","journal-title":"J Clin Virol"},{"key":"8908_CR100","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395:1054\u20131062. https:\/\/doi.org\/10.1016\/s0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"8908_CR101","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhang Z, Tian J, Xiong S (2020) Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Ann Palliat Med 9:428\u2013436. https:\/\/doi.org\/10.21037\/apm.2020.03.26","DOI":"10.21037\/apm.2020.03.26"},{"key":"8908_CR102","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","volume":"95","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z et al (2020) Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis 95:332\u2013339. https:\/\/doi.org\/10.1016\/j.ijid.2020.04.041","journal-title":"Int J Infect Dis"},{"key":"8908_CR103","doi-asserted-by":"publisher","unstructured":"Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA et al (2021) An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 6. https:\/\/doi.org\/10.1172\/jci.insight.144455","DOI":"10.1172\/jci.insight.144455"},{"key":"8908_CR104","doi-asserted-by":"publisher","first-page":"117727192110270","DOI":"10.1177\/11772719211027022","volume":"16","author":"G A\u00e7\u0131ksar\u0131","year":"2021","unstructured":"A\u00e7\u0131ksar\u0131 G, Ko\u00e7ak M, \u00c7a\u011f Y, Altunal LN, At\u0131c\u0131 A, \u00c7elik FB et al (2021) Prognostic value of inflammatory biomarkers in patients with severe COVID-19: A single-center retrospective study. Biomark Insights 16:11772719211027022. https:\/\/doi.org\/10.1177\/11772719211027022","journal-title":"Biomark Insights"},{"key":"8908_CR105","doi-asserted-by":"publisher","first-page":"215013272110414","DOI":"10.1177\/21501327211041486","volume":"12","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Kumar P, Shekhar S, Saha R, Ranjan A, Pandey S (2021) Epidemiological, clinical, and laboratory predictors of in-hospital mortality among COVID-19 patients admitted in a tertiary COVID dedicated hospital, Northern India: A retrospective observational study. J Prim Care Community Health 12:21501327211041490. https:\/\/doi.org\/10.1177\/21501327211041486","journal-title":"J Prim Care Community Health"},{"key":"8908_CR106","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3855\/jidc.14072","volume":"15","author":"D Akdogan","year":"2021","unstructured":"Akdogan D, Guzel M, Tosun D, Akpinar O (2021) Diagnostic and early prognostic value of serum CRP and LDH levels in patients with possible COVID-19 at the first admission. J Infect Dev Ctries 15:766\u2013772. https:\/\/doi.org\/10.3855\/jidc.14072","journal-title":"J Infect Dev Ctries"},{"key":"8908_CR107","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ajem.2020.08.076","volume":"45","author":"G Aksel","year":"2021","unstructured":"Aksel G, \u0130slam MM, Alg\u0131n A, Ero\u011flu SE, Ya\u015far GB, Ademo\u011flu E et al (2021) Early predictors of mortality for moderate to severely ill patients with Covid-19. Am J Emerg Med 45:290\u2013296. https:\/\/doi.org\/10.1016\/j.ajem.2020.08.076","journal-title":"Am J Emerg Med"},{"key":"8908_CR108","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jiph.2021.06.005","volume":"14","author":"O Albalawi","year":"2021","unstructured":"Albalawi O, Alharbi Y, Bakouri M, Alqahtani A, Alanazi T, Almutairi AZ et al (2021) Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia. J Infect Public Health 14:994\u20131000. https:\/\/doi.org\/10.1016\/j.jiph.2021.06.005","journal-title":"J Infect Public Health"},{"key":"8908_CR109","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40001-021-00517-7","volume":"26","author":"S Alhumaid","year":"2021","unstructured":"Alhumaid S, Al Mutair A, Al Alawi Z, Al Salman K, Al Dossary N, Omar A et al (2021) Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: An experience cohort from Alahsa, Saudi Arabia. Eur J Med Res 26:47. https:\/\/doi.org\/10.1186\/s40001-021-00517-7","journal-title":"Eur J Med Res"},{"key":"8908_CR110","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/jbm.S316681","volume":"12","author":"MM Aly","year":"2021","unstructured":"Aly MM, Meshref TS, Abdelhameid MA, Ahmed SA, Shaltout AS, Abdel-Moniem AE et al (2021) Can hematological ratios predict outcome of COVID-19 patients? A multicentric study. J Blood Med 12:505\u2013515. https:\/\/doi.org\/10.2147\/jbm.S316681","journal-title":"J Blood Med"},{"key":"8908_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256023","volume":"16","author":"H Arikan","year":"2021","unstructured":"Arikan H, Ozturk S, Tokgoz B, Dursun B, Seyahi N, Trabulus S et al (2021) Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology. PLoS One 16:e0256023. https:\/\/doi.org\/10.1371\/journal.pone.0256023","journal-title":"PLoS One"},{"key":"8908_CR112","doi-asserted-by":"publisher","first-page":"8863053","DOI":"10.1155\/2021\/8863053","volume":"2021","author":"M Bellan","year":"2021","unstructured":"Bellan M, Azzolina D, Hayden E, Gaidano G, Pirisi M, Acquaviva A et al (2021) Simple parameters from complete blood count predict in-hospital mortality in COVID-19. Dis Markers 2021:8863053. https:\/\/doi.org\/10.1155\/2021\/8863053","journal-title":"Dis Markers"},{"key":"8908_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155455","volume":"141","author":"L Bergantini","year":"2021","unstructured":"Bergantini L, Bargagli E, d\u2019Alessandro M, Refini RM, Cameli P, Galasso L et al (2021) Prognostic bioindicators in severe COVID-19 patients. Cytokine 141:155455. https:\/\/doi.org\/10.1016\/j.cyto.2021.155455","journal-title":"Cytokine"},{"key":"8908_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248829","volume":"16","author":"M Betti","year":"2021","unstructured":"Betti M, Bertolotti M, Ferrante D, Roveta A, Pelazza C, Giacchero F et al (2021) Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged \u2264 65 years: A retrospective observational study. PLoS One 16:e0248829. https:\/\/doi.org\/10.1371\/journal.pone.0248829","journal-title":"PLoS One"},{"key":"8908_CR115","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12622","volume":"13","author":"S Bg","year":"2021","unstructured":"Bg S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Sharma A et al (2021) Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte ratios: Prognostic significance in COVID-19. Cureus 13:e12622. https:\/\/doi.org\/10.7759\/cureus.12622","journal-title":"Cureus"},{"key":"8908_CR116","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaip.2020.10.043","volume":"9","author":"L Cai","year":"2021","unstructured":"Cai L, Zhou X, Wang M, Mei H, Ai L, Mu S et al (2021) Predictive nomogram for severe COVID-19 and identification of mortality-related immune features. J Allergy Clin Immunol Pract 9:177-184.e173. https:\/\/doi.org\/10.1016\/j.jaip.2020.10.043","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8908_CR117","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024750","volume":"100","author":"A Capdevila-Reniu","year":"2021","unstructured":"Capdevila-Reniu A, Pellice M, Prieto-Gonz\u00e1lez S, Ventosa H, Ladino A, Naval J et al (2021) Clinical characteristics and outcome of patients aged over 80 years with covid-19. Medicine (Baltimore) 100:e24750. https:\/\/doi.org\/10.1097\/md.0000000000024750","journal-title":"Medicine (Baltimore)"},{"key":"8908_CR118","doi-asserted-by":"publisher","first-page":"6615787","DOI":"10.1155\/2021\/6615787","volume":"2021","author":"I Cekerevac","year":"2021","unstructured":"Cekerevac I, Turnic TN, Draginic N, Andjic M, Zivkovic V, Simovic S et al (2021) Predicting severity and intrahospital mortality in COVID-19: The place and role of oxidative stress. Oxid Med Cell Longev 2021:6615787. https:\/\/doi.org\/10.1155\/2021\/6615787","journal-title":"Oxid Med Cell Longev"},{"key":"8908_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719544","volume":"12","author":"PK Chen","year":"2021","unstructured":"Chen PK, Lan JL, Huang PH, Hsu JL, Chang CK, Tien N et al (2021) Interleukin-18 is a potential biomarker to discriminate active adult-onset still\u2019s disease from COVID-19. Front Immunol 12:719544. https:\/\/doi.org\/10.3389\/fimmu.2021.719544","journal-title":"Front Immunol"},{"key":"8908_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247758","volume":"16","author":"W Conca","year":"2021","unstructured":"Conca W, Alabdely M, Albaiz F, Foster MW, Alamri M, Alkaff M et al (2021) Serum \u03b22-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity? PLoS One 16:e0247758. https:\/\/doi.org\/10.1371\/journal.pone.0247758","journal-title":"PLoS One"},{"key":"8908_CR121","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/jmv.26577","volume":"93","author":"M d\u2019Alessandro","year":"2021","unstructured":"d\u2019Alessandro M, Bergantini L, Cameli P, Curatola G, Remediani L, Sestini P et al (2021) Peripheral biomarkers\u2019 panel for severe COVID-19 patients. J Med Virol 93:1230\u20131232. https:\/\/doi.org\/10.1002\/jmv.26577","journal-title":"J Med Virol"},{"key":"8908_CR122","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/jmv.26793","volume":"93","author":"K Deng","year":"2021","unstructured":"Deng K, Fan Q, Yang Y, Deng X, He R, Tan Y et al (2021) Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis. J Med Virol 93:2505\u20132512. https:\/\/doi.org\/10.1002\/jmv.26793","journal-title":"J Med Virol"},{"key":"8908_CR123","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/20477724.2021.1893485","volume":"115","author":"M Eleni","year":"2021","unstructured":"Eleni M, Evangelia M, Eleftheria K, Vasilios V, Vana S, Vissaria S et al (2021) Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region. Pathog Glob Health 115:243\u2013249. https:\/\/doi.org\/10.1080\/20477724.2021.1893485","journal-title":"Pathog Glob Health"},{"key":"8908_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251085","volume":"16","author":"M Elhadi","year":"2021","unstructured":"Elhadi M, Alsoufi A, Abusalama A, Alkaseek A, Abdeewi S, Yahya M et al (2021) Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study. PLoS One 16:e0251085. https:\/\/doi.org\/10.1371\/journal.pone.0251085","journal-title":"PLoS One"},{"key":"8908_CR125","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13511","volume":"51","author":"L Garc\u00eda de Guadiana-Romualdo","year":"2021","unstructured":"Garc\u00eda de Guadiana-Romualdo L, Calvo Nieves MD, Rodr\u00edguez Mulero MD, Calcerrada Alises I, Hern\u00e1ndez Olivo M, Trapiello Fern\u00e1ndez W et al (2021) MR-proADM as marker of endotheliitis predicts COVID-19 severity. Eur J Clin Invest 51:e13511. https:\/\/doi.org\/10.1111\/eci.13511","journal-title":"Eur J Clin Invest"},{"key":"8908_CR126","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.4049\/jimmunol.2001327","volume":"206","author":"W Huang","year":"2021","unstructured":"Huang W, Li M, Luo G, Wu X, Su B, Zhao L et al (2021) The inflammatory factors associated with disease severity to predict COVID-19 progression. J Immunol 206:1597\u20131608. https:\/\/doi.org\/10.4049\/jimmunol.2001327","journal-title":"J Immunol"},{"key":"8908_CR127","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/emermed-2020-211027","volume":"38","author":"A Kaal","year":"2021","unstructured":"Kaal A, Snel L, Dane M, van Burgel N, Ottens T, Broekman W et al (2021) Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department. Emerg Med J 38:685\u2013691. https:\/\/doi.org\/10.1136\/emermed-2020-211027","journal-title":"Emerg Med J"},{"key":"8908_CR128","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12603-020-1479-0","volume":"25","author":"S Karahan","year":"2021","unstructured":"Karahan S, Katkat F (2021) Impact of serum 25(OH) vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 25:189\u2013196. https:\/\/doi.org\/10.1007\/s12603-020-1479-0","journal-title":"J Nutr Health Aging"},{"key":"8908_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107684","volume":"97","author":"S Karampoor","year":"2021","unstructured":"Karampoor S, Zahednasab H, Farahmand M, Mirzaei R, Zamani F, Tabibzadeh A et al (2021) A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol 97:107684. https:\/\/doi.org\/10.1016\/j.intimp.2021.107684","journal-title":"Int Immunopharmacol"},{"key":"8908_CR130","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.clnu.2020.09.040","volume":"40","author":"G Li","year":"2021","unstructured":"Li G, Zhou CL, Ba YM, Wang YM, Song B, Cheng XB et al (2021) Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study. Clin Nutr 40:2154\u20132161. https:\/\/doi.org\/10.1016\/j.clnu.2020.09.040","journal-title":"Clin Nutr"},{"key":"8908_CR131","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s11739-020-02560-4","volume":"16","author":"T Li","year":"2021","unstructured":"Li T, Wang X, Zhuang X, Wang H, Li A, Huang L et al (2021) Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19. Intern Emerg Med 16:1165\u20131172. https:\/\/doi.org\/10.1007\/s11739-020-02560-4","journal-title":"Intern Emerg Med"},{"key":"8908_CR132","doi-asserted-by":"publisher","unstructured":"Li Z, Jiang N, Li X, Yang B, Jin M, Sun Y et al (2021) Two novel nomograms based on inflammatory cytokines or lymphocyte subsets to differentially diagnose severe or critical and Non-Severe COVID-19. Aging (Albany NY) 13. https:\/\/doi.org\/10.18632\/aging.203307","DOI":"10.18632\/aging.203307"},{"key":"8908_CR133","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000023996","volume":"100","author":"J Liu","year":"2021","unstructured":"Liu J, Tu C, Zhu M, Wang J, Yang C, Liu W et al (2021) The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study. Medicine (Baltimore) 100:e23996. https:\/\/doi.org\/10.1097\/md.0000000000023996","journal-title":"Medicine (Baltimore)"},{"key":"8908_CR134","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/vim.2020.0062","volume":"34","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liao W, Wan L, Xiang T, Zhang W (2021) Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19. Viral Immunol 34:330\u2013335. https:\/\/doi.org\/10.1089\/vim.2020.0062","journal-title":"Viral Immunol"},{"key":"8908_CR135","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jim-2021-001810","volume":"69","author":"A L\u00f3pez-Escobar","year":"2021","unstructured":"L\u00f3pez-Escobar A, Madurga R, Castellano JM, Ruiz de Aguiar S, Vel\u00e1zquez S, Bucar M et al (2021) Hemogram as marker of in-hospital mortality in COVID-19. J Investig Med 69:962\u2013969. https:\/\/doi.org\/10.1136\/jim-2021-001810","journal-title":"J Investig Med"},{"key":"8908_CR136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12941-020-00412-9","volume":"20","author":"Y Lu","year":"2021","unstructured":"Lu Y, Huang Z, Wang M, Tang K, Wang S, Gao P et al (2021) Clinical characteristics and predictors of mortality in young adults with severe COVID-19: A retrospective observational study. Ann Clin Microbiol Antimicrob 20:3. https:\/\/doi.org\/10.1186\/s12941-020-00412-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"8908_CR137","doi-asserted-by":"publisher","unstructured":"Mar\u00edn-Corral J, Rodr\u00edguez-Morat\u00f3 J, Gomez-Gomez A, Pascual-Guardia S, Mu\u00f1oz-Berm\u00fadez R, Salazar-Degracia A et al (2021) Metabolic signatures associated with severity in hospitalized COVID-19 patients. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22094794","DOI":"10.3390\/ijms22094794"},{"key":"8908_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246771","volume":"16","author":"G Montrucchio","year":"2021","unstructured":"Montrucchio G, Sales G, Rumbolo F, Palmesino F, Fanelli V, Urbino R et al (2021) Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS One 16:e0246771. https:\/\/doi.org\/10.1371\/journal.pone.0246771","journal-title":"PLoS One"},{"key":"8908_CR139","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10147-020-01837-0","volume":"26","author":"S Nakamura","year":"2021","unstructured":"Nakamura S, Kanemasa Y, Atsuta Y, Fujiwara S, Tanaka M, Fukushima K et al (2021) Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: A single-center retrospective observational study in Tokyo, Japan. Int J Clin Oncol 26:485\u2013493. https:\/\/doi.org\/10.1007\/s10147-020-01837-0","journal-title":"Int J Clin Oncol"},{"key":"8908_CR140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.hrtlng.2020.10.013","volume":"50","author":"SA \u00d1amendys-Silva","year":"2021","unstructured":"\u00d1amendys-Silva SA, Alvarado-\u00c1vila PE, Dom\u00ednguez-Cherit G, Rivero-Sigarroa E, S\u00e1nchez-Hurtado LA, Guti\u00e9rrez-Villase\u00f1or A et al (2021) Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study. Heart Lung 50:28\u201332. https:\/\/doi.org\/10.1016\/j.hrtlng.2020.10.013","journal-title":"Heart Lung"},{"key":"8908_CR141","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jelectrocard.2021.01.016","volume":"65","author":"\u0130H \u00d6zdemir","year":"2021","unstructured":"\u00d6zdemir \u0130H, \u00d6zlek B, \u00c7etin N (2021) Permanent atrial fibrillation portends poor outcomes in hospitalized patients with COVID-19: A retrospective observational study. J Electrocardiol 65:113\u2013120. https:\/\/doi.org\/10.1016\/j.jelectrocard.2021.01.016","journal-title":"J Electrocardiol"},{"key":"8908_CR142","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/1354750x.2021.1874052","volume":"26","author":"\u00d3M Peir\u00f3","year":"2021","unstructured":"Peir\u00f3 \u00d3M, Carrasquer A, S\u00e1nchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G et al (2021) Biomarkers and short-term prognosis in COVID-19. Biomarkers 26:119\u2013126. https:\/\/doi.org\/10.1080\/1354750x.2021.1874052","journal-title":"Biomarkers"},{"key":"8908_CR143","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lungcan.2021.05.014","volume":"157","author":"M Provencio","year":"2021","unstructured":"Provencio M, Mazarico Gallego JM, Calles A, Anto\u00f1anzas M, Pangua C, Mielgo Rubio X et al (2021) Lung cancer patients with COVID-19 in Spain: GRAVID study. Lung Cancer 157:109\u2013115. https:\/\/doi.org\/10.1016\/j.lungcan.2021.05.014","journal-title":"Lung Cancer"},{"key":"8908_CR144","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/hum.2020.255","volume":"32","author":"W Qin","year":"2021","unstructured":"Qin W, Bai W, Liu K, Liu Y, Meng X, Zhang K et al (2021) Clinical course and risk factors of disease deterioration in critically ill patients with COVID-19. Hum Gene Ther 32:310\u2013315. https:\/\/doi.org\/10.1089\/hum.2020.255","journal-title":"Hum Gene Ther"},{"key":"8908_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155438","volume":"140","author":"L Quartuccio","year":"2021","unstructured":"Quartuccio L, Fabris M, Sonaglia A, Peghin M, Domenis R, Cif\u00f9 A et al (2021) Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine 140:155438. https:\/\/doi.org\/10.1016\/j.cyto.2021.155438","journal-title":"Cytokine"},{"key":"8908_CR146","doi-asserted-by":"publisher","unstructured":"Sai F, Liu X, Li L, Ye Y, Zhu C, Hang Y et al (2021) Clinical characteristics and risk factors for mortality in patients with coronavirus disease 2019 in intensive care unit: A single-center, retrospective, observational study in China. Ann Palliat Med 10:2859\u20132868. https:\/\/doi.org\/10.21037\/apm-20-1575","DOI":"10.21037\/apm-20-1575"},{"key":"8908_CR147","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.1038\/s41598-021-92400-y","volume":"11","author":"S Salto-Alejandre","year":"2021","unstructured":"Salto-Alejandre S, Berastegui-Cabrera J, Camacho-Mart\u00ednez P, Infante-Dom\u00ednguez C, Carretero-Ledesma M, Crespo-Rivas JC et al (2021) SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome. Sci Rep 11:12931. https:\/\/doi.org\/10.1038\/s41598-021-92400-y","journal-title":"Sci Rep"},{"key":"8908_CR148","doi-asserted-by":"publisher","unstructured":"Scotto R, Pinchera B, Perna F, Atripaldi L, Giaccone A, Sequino D et al (2021) Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia. Int J Environ Res Public Health 18. https:\/\/doi.org\/10.3390\/ijerph18042078","DOI":"10.3390\/ijerph18042078"},{"key":"8908_CR149","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12937-021-00702-8","volume":"20","author":"F Song","year":"2021","unstructured":"Song F, Ma H, Wang S, Qin T, Xu Q, Yuan H et al (2021) Nutritional screening based on objective indices at admission predicts in-hospital mortality in patients with COVID-19. Nutr J 20:46. https:\/\/doi.org\/10.1186\/s12937-021-00702-8","journal-title":"Nutr J"},{"key":"8908_CR150","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/s41598-021-84478-1","volume":"11","author":"E Sozio","year":"2021","unstructured":"Sozio E, Tascini C, Fabris M, D\u2019Aurizio F, De Carlo C, Graziano E et al (2021) MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep 11:5121. https:\/\/doi.org\/10.1038\/s41598-021-84478-1","journal-title":"Sci Rep"},{"key":"8908_CR151","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5603\/ARM.a2021.0035","volume":"89","author":"T Stachura","year":"2021","unstructured":"Stachura T, Celejewska-W\u00f3jcik N, Polok K, G\u00f3rka K, Licho\u0142ai S, W\u00f3jcik K et al (2021) A clinical profile and factors associated with severity of the disease among Polish patients hospitalized due to COVID-19 - an observational study. Adv Respir Med 89:124\u2013134. https:\/\/doi.org\/10.5603\/ARM.a2021.0035","journal-title":"Adv Respir Med"},{"key":"8908_CR152","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000026131","volume":"100","author":"J Tang","year":"2021","unstructured":"Tang J, Lin J, Zhang E, Zhong M, Luo Y, Fu Y et al (2021) Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients. Medicine (Baltimore) 100:e26131. https:\/\/doi.org\/10.1097\/md.0000000000026131","journal-title":"Medicine (Baltimore)"},{"key":"8908_CR153","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jmv.26444","volume":"93","author":"Z Tao","year":"2021","unstructured":"Tao Z, Xu J, Chen W, Yang Z, Xu X, Liu L et al (2021) Anemia is associated with severe illness in COVID-19: A retrospective cohort study. J Med Virol 93:1478\u20131488. https:\/\/doi.org\/10.1002\/jmv.26444","journal-title":"J Med Virol"},{"key":"8908_CR154","doi-asserted-by":"publisher","unstructured":"Tepasse PR, Vollenberg R, Fobker M, Kabar I, Schmidt H, Meier JA et al (2021) Vitamin A plasma levels in COVID-19 patients: A prospective multicenter study and hypothesis. Nutrients 13. https:\/\/doi.org\/10.3390\/nu13072173","DOI":"10.3390\/nu13072173"},{"key":"8908_CR155","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.medcli.2020.12.018","volume":"156","author":"MC Viana-Llamas","year":"2021","unstructured":"Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obreg\u00f3n JA, Uribe-Heredia G, N\u00fa\u00f1ez-Gil I, Garc\u00eda-Magall\u00f3n B et al (2021) Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events: A retrospective observational study. Med Clin (Barc) 156:428\u2013436. https:\/\/doi.org\/10.1016\/j.medcli.2020.12.018","journal-title":"Med Clin (Barc)"},{"key":"8908_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.667487","volume":"11","author":"M Wang","year":"2021","unstructured":"Wang M, Fan Y, Chai Y, Cheng W, Wang K, Cao J et al (2021) Association of clinical and immunological characteristics with disease severity and outcomes in 211 patients with COVID-19 in Wuhan, China. Front Cell Infect Microbiol 11:667487. https:\/\/doi.org\/10.3389\/fcimb.2021.667487","journal-title":"Front Cell Infect Microbiol"},{"key":"8908_CR157","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12879-021-05814-4","volume":"21","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wang Z (2021) Identification of risk factors for in-hospital death of COVID - 19 pneumonia \u2013 lessions from the early outbreak. BMC Infect Dis 21:113. https:\/\/doi.org\/10.1186\/s12879-021-05814-4","journal-title":"BMC Infect Dis"},{"key":"8908_CR158","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23809","volume":"35","author":"A Waris","year":"2021","unstructured":"Waris A, Din M, Khalid A, Abbas Lail R, Shaheen A, Khan N et al (2021) Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan\u2019s experience. J Clin Lab Anal 35:e23809. https:\/\/doi.org\/10.1002\/jcla.23809","journal-title":"J Clin Lab Anal"},{"key":"8908_CR159","doi-asserted-by":"publisher","unstructured":"Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W et al (2021) Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 13:6289\u20136297. https:\/\/doi.org\/10.18632\/aging.202819","DOI":"10.18632\/aging.202819"},{"key":"8908_CR160","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.7150\/ijbs.58825","volume":"17","author":"M Xue","year":"2021","unstructured":"Xue M, Zhang T, Chen H, Zeng Y, Lin R, Zhen Y et al (2021) Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients. Int J Biol Sci 17:1565\u20131573. https:\/\/doi.org\/10.7150\/ijbs.58825","journal-title":"Int J Biol Sci"},{"key":"8908_CR161","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijcard.2020.09.048","volume":"326","author":"C Yang","year":"2021","unstructured":"Yang C, Liu F, Liu W, Cao G, Liu J, Huang S et al (2021) Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol 326:230\u2013236. https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.048","journal-title":"Int J Cardiol"},{"key":"8908_CR162","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.1111\/aor.13873","volume":"45","author":"R Zayat","year":"2021","unstructured":"Zayat R, Kalverkamp S, Grottke O, Durak K, Dreher M, Autschbach R et al (2021) Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality. Artif Organs 45:E158-e170. https:\/\/doi.org\/10.1111\/aor.13873","journal-title":"Artif Organs"},{"key":"8908_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.581469","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang Z, Wang X, Hu Z, Yang C, Lei P (2021) Risk factors for mortality of COVID-19 patient based on clinical course: A single center retrospective case-control study. Front Immunol 12:581469. https:\/\/doi.org\/10.3389\/fimmu.2021.581469","journal-title":"Front Immunol"},{"key":"8908_CR164","doi-asserted-by":"publisher","unstructured":"Zhao Y, Yu C, Ni W, Shen H, Qiu M, Zhao Y (2021) Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A. J Clin Lab Anal 35:e23657. https:\/\/doi.org\/10.1002\/jcla.23657","DOI":"10.1002\/jcla.23657"},{"key":"8908_CR165","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14348","author":"SJ Elberts","year":"2021","unstructured":"Elberts SJ, Bateman R, Koutsoubis A, London KS, White JL, Fields JM (2021) The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. https:\/\/doi.org\/10.1111\/acem.14348","journal-title":"Acad Emerg Med"},{"key":"8908_CR166","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/0036933021994243","volume":"66","author":"G Liu","year":"2021","unstructured":"Liu G, Zhang B, Zhang S, Hu H, Liu T (2021) LDH, CRP and ALB predict nucleic acid turn negative within 14 days in symptomatic patients with COVID-19. Scott Med J 66:108\u2013114. https:\/\/doi.org\/10.1177\/0036933021994243","journal-title":"Scott Med J"},{"key":"8908_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.734005","volume":"11","author":"J Sui","year":"2021","unstructured":"Sui J, Noubouossie DF, Gandotra S, Cao L (2021) Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients. Front Cell Infect Microbiol 11:734005. https:\/\/doi.org\/10.3389\/fcimb.2021.734005","journal-title":"Front Cell Infect Microbiol"},{"key":"8908_CR168","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.numecd.2020.04.013","volume":"30","author":"M Li","year":"2020","unstructured":"Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z et al (2020) Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr Metab Cardiovasc Dis 30:1061\u20131067. https:\/\/doi.org\/10.1016\/j.numecd.2020.04.013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"8908_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01037-9","author":"J Loske","year":"2021","unstructured":"Loske J, R\u00f6hmel J, Lukassen S, Stricker S, Magalh\u00e3es VG, Liebig J et al (2021) Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-01037-9","journal-title":"Nat Biotechnol"},{"key":"8908_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104673","volume":"150","author":"S Choudhary","year":"2021","unstructured":"Choudhary S, Sharma K, Silakari O (2021) The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microb Pathog 150:104673. https:\/\/doi.org\/10.1016\/j.micpath.2020.104673","journal-title":"Microb Pathog"},{"key":"8908_CR171","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","volume":"11","author":"LF Garc\u00eda","year":"2020","unstructured":"Garc\u00eda LF (2020) Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol 11:1441. https:\/\/doi.org\/10.3389\/fimmu.2020.01441","journal-title":"Front Immunol"},{"key":"8908_CR172","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol 20:363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"8908_CR173","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R (2020) The COVID-19 cytokine storm; What we know so far. Front Immunol 11:1446. https:\/\/doi.org\/10.3389\/fimmu.2020.01446","journal-title":"Front Immunol"},{"key":"8908_CR174","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41577-021-00553-8","volume":"21","author":"SA Jones","year":"2021","unstructured":"Jones SA, Hunter CA (2021) Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol 21:337\u2013339. https:\/\/doi.org\/10.1038\/s41577-021-00553-8","journal-title":"Nat Rev Immunol"},{"key":"8908_CR175","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2021.03.008","volume":"82","author":"E Tharmarajah","year":"2021","unstructured":"Tharmarajah E, Buazon A, Patel V, Hannah JR, Adas M, Allen VB et al (2021) IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression. J Infect 82:178\u2013185. https:\/\/doi.org\/10.1016\/j.jinf.2021.03.008","journal-title":"J Infect"},{"key":"8908_CR176","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26:1636\u20131643. https:\/\/doi.org\/10.1038\/s41591-020-1051-9","journal-title":"Nat Med"},{"key":"8908_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.677008","volume":"12","author":"H Islam","year":"2021","unstructured":"Islam H, Chamberlain TC, Mui AL, Little JP (2021) Elevated Interleukin-10 levels in COVID-19: Potentiation of rro-inflammatory responses or impaired anti-inflammatory action? Front Immunol 12:677008. https:\/\/doi.org\/10.3389\/fimmu.2021.677008","journal-title":"Front Immunol"},{"key":"8908_CR178","doi-asserted-by":"publisher","unstructured":"Acosta MAT, Singer BD (2020) Pathogenesis of COVID-19-induced ARDS: Implications for an ageing population. Eur Respir J 56. https:\/\/doi.org\/10.1183\/13993003.02049-2020","DOI":"10.1183\/13993003.02049-2020"},{"key":"8908_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106051","volume":"56","author":"R Hu","year":"2020","unstructured":"Hu R, Han C, Pei S, Yin M, Chen X (2020) Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents 56:106051. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106051","journal-title":"Int J Antimicrob Agents"},{"key":"8908_CR180","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cca.2021.04.022","volume":"519","author":"Z Chen","year":"2021","unstructured":"Chen Z, Xu W, Ma W, Shi X, Li S, Hao M et al (2021) Clinical laboratory evaluation of COVID-19. Clin Chim Acta 519:172\u2013182. https:\/\/doi.org\/10.1016\/j.cca.2021.04.022","journal-title":"Clin Chim Acta"},{"key":"8908_CR181","doi-asserted-by":"publisher","unstructured":"Zhang J, Liu P, Wang M, Wang J, Chen J, Yuan W et al (2020) The clinical data from 19 critically ill patients with coronavirus disease 2019: A single-centered, retrospective, observational study. Z Gesundh Wiss 1\u20134. https:\/\/doi.org\/10.1007\/s10389-020-01291-2","DOI":"10.1007\/s10389-020-01291-2"},{"key":"8908_CR182","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2199","volume":"31","author":"APD Iwamura","year":"2021","unstructured":"Iwamura APD, Tavares da Silva MR, H\u00fcmmelgen AL, Soeiro Pereira PV, Falcai A, Grumach AS et al (2021) Immunity and inflammatory biomarkers in COVID-19: A systematic review. Rev Med Virol 31:e2199. https:\/\/doi.org\/10.1002\/rmv.2199","journal-title":"Rev Med Virol"},{"key":"8908_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243124","volume":"15","author":"L Yang","year":"2020","unstructured":"Yang L, Jin J, Luo W, Gan Y, Chen B, Li W (2020) Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis. PLoS One 15:e0243124. https:\/\/doi.org\/10.1371\/journal.pone.0243124","journal-title":"PLoS One"},{"key":"8908_CR184","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M et al (2020) Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 71:2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530","journal-title":"Clin Infect Dis"},{"key":"8908_CR185","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/s0140-6736(20)30691-7","volume":"395","author":"AI Ritchie","year":"2020","unstructured":"Ritchie AI, Singanayagam A (2020) Immunosuppression for hyperinflammation in COVID-19: A double-edged sword? Lancet 395:1111. https:\/\/doi.org\/10.1016\/s0140-6736(20)30691-7","journal-title":"Lancet"},{"key":"8908_CR186","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/cyto.a.24172","volume":"97","author":"W Huang","year":"2020","unstructured":"Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T et al (2020) Lymphocyte subset counts in COVID-19 patients: A meta-analysis. Cytometry A 97:772\u2013776. https:\/\/doi.org\/10.1002\/cyto.a.24172","journal-title":"Cytometry A"},{"key":"8908_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","volume":"146","author":"AW Lindsley","year":"2020","unstructured":"Lindsley AW, Schwartz JT, Rothenberg ME (2020) Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 146:1\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.021","journal-title":"J Allergy Clin Immunol"},{"key":"8908_CR188","doi-asserted-by":"publisher","first-page":"107602962096285","DOI":"10.1177\/1076029620962853","volume":"26","author":"A Kichloo","year":"2020","unstructured":"Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J et al (2020) COVID-19 and hypercoagulability: A review. Clin Appl Thromb Hemost 26:1076029620962853. https:\/\/doi.org\/10.1177\/1076029620962853","journal-title":"Clin Appl Thromb Hemost"},{"key":"8908_CR189","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418. https:\/\/doi.org\/10.1016\/s0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"8908_CR190","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"key":"8908_CR191","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/s2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2:e437\u2013e445. https:\/\/doi.org\/10.1016\/s2665-9913(20)30121-1","journal-title":"Lancet Rheumatol"},{"key":"8908_CR192","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM et al (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 39:618\u2013625. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02153.x","journal-title":"Eur J Clin Invest"},{"key":"8908_CR193","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE et al (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822\u2013828. https:\/\/doi.org\/10.1038\/nature00786","journal-title":"Nature"},{"key":"8908_CR194","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","volume":"75","author":"GY Oudit","year":"2007","unstructured":"Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH et al (2007) Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75:29\u201339. https:\/\/doi.org\/10.1016\/j.cardiores.2007.04.007","journal-title":"Cardiovasc Res"},{"key":"8908_CR195","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1074\/jbc.M708033200","volume":"283","author":"X Zhao","year":"2008","unstructured":"Zhao X, Nicholls JM, Chen YG (2008) Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem 283:3272\u20133280. https:\/\/doi.org\/10.1074\/jbc.M708033200","journal-title":"J Biol Chem"},{"key":"8908_CR196","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH et al (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136:95\u2013103. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02415.x","journal-title":"Clin Exp Immunol"},{"key":"8908_CR197","doi-asserted-by":"publisher","unstructured":"Chen DF, Chen Y, Zhong CH, Chen XB, Li SY (2021) Long-term efficacy and safety of the Dumon stent for benign tracheal stenosis: a meta-analysis. J Thorac Dis 13:82\u201391. https:\/\/doi.org\/10.21037\/jtd-20-2327","DOI":"10.21037\/jtd-20-2327"},{"key":"8908_CR198","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jaip.2017.02.002","volume":"5","author":"A Alhossan","year":"2017","unstructured":"Alhossan A, Lee CS, MacDonald K, Abraham I (2017) Real-life effectiveness studies of omalizumab in adult patients with severe allergic asthma: Meta-analysis. J Allergy Clin Immunol Pract 5:1362-1370.e1362. https:\/\/doi.org\/10.1016\/j.jaip.2017.02.002","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08908-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T07:15:18Z","timestamp":1674458118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08908-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["8908"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08908-8","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"29 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the current study did not involve human subjects, the Ethics Committee at the First Affiliated Hospital of Guangzhou Medical University exempted this study from the need for ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"PROSPERO CRD42020196272.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study Registration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}